Article
Healthcare & Life Sciences Private Equity Deal Tracker: Mederi Therapeutics Secures $18.5 Million In Funding
Mederi Therapeutics Inc. has announced it has secured $18.5 million in funding comprised of Series B preferred stock and venture debt.

McGuireWoods LLP
